Answers are grounded in this paper and cite their sources.
The study documented benefits of semaglutide on metabolic control and multiple CV risk factors, simplification of therapeutic schemes and high satisfaction with diabetes treatment, and eating behaviors indicative of healthy diet and reduced food intake.
No takes yet. Share an insight, caveat, or question.
Folco et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: